Ipilimumab-Induced Sarcoidosis and Thyroiditis
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference10 articles.
1. Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings;Lens;Recent Pat Anticancer Drug Discov.,2008
2. Moving forward with immunotherapy: the rationale for anti-CTLA-4 therapy in melanoma;Margolin;Commun Oncol.,2008
3. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade;Maker;J Immunol.,2005
4. Management of immunerelated adverse events and kinetics of response with ipilimumab;Weber;J Clin Oncol.,2012
5. Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy;Suozzi;JAAD Case Rep.,2016
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Differential diagnosis of pulmonary sarcoidosis: a review;Frontiers in Medicine;2023-05-12
2. Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review;Cancers;2023-04-29
3. Oncologic Emergencies;Holland‐Frei Cancer Medicine;2022-10-21
4. Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma;Cancers;2022-06-14
5. Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review;BMJ Open Ophthalmology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3